IKF Pneumologie GmbH & Co. KG — Clinical Trial Site

65 Registered trials

23 Currently recruiting

Organisation

IKF Pneumologie GmbH & Co. KG

Location

Frankfurt Am Main, Germany

Identifier

ORG-100046278

Address

Stresemannallee 3, Sachsenhausen, 60596, Germany

Departments

-
#2604
2602: Pulmonology
2604: Helix Medical Excellence Center Mainz
2605:Institut für klinische Forschung Pneumologie
2606: Institut für klinische Forschung
276001:Pulmonology
276003:Institut für klinische Forschung Pneumologie
2nd Floor
4501: Institut für klinische Forschung Pneumologie
4518: Pulmonology
Clinical Research Center Respiratory Diseases
Clinical Research Centre Respiratory Diseases
Clinical Research Centre, Respiratory Medicine, Helix Medical Excellence Center
DE007: Pulmonology
Helix Medical Excellence Center Mainz
IKF Institut für Klinische Forschung Mainz
IKF Pneumologie GmbH & Co. KG
IKF Pneumologie GmbH & Co. KG (#1)
IKF Pneumologie Mainz
Institut für klinische Forschung Pneumologie
Institut für Klinische Forschung Pneumologie Frankfurt
Institut für klinische Forschung Pneumologie, Clinical Research Center Respiratory Diseases
Interdisziplinaeres Facharztentrum Sachsenhausen
Interdisziplinäres Facharztzentrum
Interdisziplinäres Facharztzentrum Sachsenhausen
lnstitut fuer klinische Forschung Pneumologie
N/A
N/A - Additional streetname as site is located at a corner: Stresemannallee 3
NA
Not applicable
Pneumologie
Pneumology

Clinical trials at this site (65)

Search interface

A study to find an efficacious and safe dose of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis Pending

2024-514246-37-00 Idiopathic pulmonary fibrosis (IPF) 4
A Study to Learn About the Study Medicine Called PF-07275315 in Adults with Moderate-To-Severe Long-Term Breathing Difficulty, Known by the… Pending

2024-518587-12-00 MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEAS 4
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending

2024-518821-13-00 Non-cystic Fibrosis Bronchiectasis 4
A Study to Access Activity and Safety with SAR445399 Compared with Placebo in Participants Aged 18 to 80 Years of Age with Non-Cystic Fibros… Pending

2025-523403-29-00 Non-cystic fibrosis bronchiectasis 4
BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 µg]) vs Single Inhaler ICS/LABA (200/… Pending

2025-524289-56-00 Asthma 6
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1) Recruiting

2025-521950-41-00 severe uncontrolled asthma 5 2026-06-05
Long-term safety and efficacy evaluation of lunsekimig (SAR443765) in adult participants with moderate-to-severe asthma. Recruiting

2025-522896-27-00 Asthma 4 2026-05-11
A study to investigate efficacy, safety, immunogenicity, and pharmacokinetics of GSK3862995B following repeat doses in participants with bro… Recruiting

2025-522892-27-00 Bronchiectasis 4 2026-03-21
A study to investigate airway inflammation with dupilumab subcutaneously in participants aged ≥40 to ≤85 years with chronic obstructive pulm… Recruiting

2025-521268-37-00 Respiratory tract diseases 6 2025-11-25
The AIRTIVITY TM Study: A study to find out whether BI 1291583 helps people with bronchiectasis Recruiting

2024-518589-29-00 Bronchiectasis 5 2025-08-21
Clairleaf TM: A study to test long-term treatment with BI 1291583 in people with bronchiectasis who took part in a previous study with this … Recruiting

2023-503290-38-00 Bronchiectasis 4 2023-09-05
eValuating the efficacy and safety of InitiatinG depemokImab earLy therApy iN COPD with Type 2 inflammation (VIGILANT) Recruiting

2025-521108-23-00 Chronic Obstructive Pulmonary Disease 5 2026-05-19
Therapeutic equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in subjects with mild to moderate asthma (TRECONY) Recruiting

2025-521456-35-00 Mild to moderate asthma 4 2026-04-13
A trial to learn how well AZD0292 works, how safe it is, and how it moves throughout the body over time in people with bronchiectasis and ch… Recruiting

2025-523009-14-00 Bronchiectasis with chronic pseudomonas aeruginosa colo 4 2025-12-16
A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 … Recruiting

2025-521391-58-00 Asthma 4 2025-11-28
A phase 3b study of depemokimab on airway structure and function in patients with type 2 asthma utilizing quantitative high-resolution CT an… Recruiting

2024-519976-19-00 Asthma with type 2 inflammation characterized by an eos 5 2025-11-26
A study to investigate the effect of BGF MDI compared with placebo MDI on heart and lung function in participants with COPD Recruiting

2025-521987-37-00 Chronic Obstructive Pulmonary Disease 6 2025-11-06
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Parti… Recruiting

2024-517991-39-00 Asthma 5 2025-07-22
Phase 1, Randomized, Double-blind, Placebo-Controlled, First-in-Human Single Ascending Dose Study in Healthy Participants to Assess the Safe… Recruiting

2024-517644-62-00 Mild to Moderate Asthma 1 2025-06-30
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CO… Recruiting

2023-508760-29-00 Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) 5 2024-10-21
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C… Recruiting

2023-507407-59-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2024-07-04
A Phase 1 Study to Investigate the Safety and Tolerability of the Study Drug GB-0895 in Mild to Moderate Asthma Patients or Single Dose in C… Recruiting

2023-507611-35-00 mild to moderate asthma 1 2024-03-01
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants with Severe Asthma Ended

2024-519469-23-00 Severe Asthma 4 2025-10-20
Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD) Ended

2025-520488-42-00 Moderate-to-Severe Chronic Obstructive Pulmonary Diseas 4 2025-09-17